$VRTX.US – Vertex Pharmaceutical Inc ranked positive on August 24, 2021
Reshma Kewalramani (Vertex Pharmaceutical Inc CEO since 2020, joined 2018) purchased $2.0 million of stock on the 19th August at $195.65, increasing his holding by 16%. This is a notable trade as it is his first buy since joining the company and he has been a regular seller of options and stock via 10b5-1 program […]